宏達高科(002144.SZ):新航醫療辦理完成工商註冊手續
格隆匯 8 月 3日丨宏達高科(002144.SZ)公佈,根據公司於2020年7月21日召開的總經理辦公會審議通過的《關於公司對外投資設立控股子公司的議案》,公司同意與自然人高星以現金方式,共同出資設立浙江嘉興新航醫療器械有限公司(“新航醫療”),新航醫療的註冊資本為人民幣1000萬元,公司持有其70%的股份,自然人高星持有其30%的股份。
近日,新航醫療辦理完成了工商註冊手續,取得了海寧市市場監督管理局頒發的營業執照,其經營範圍:許可項目:第三類醫療器械經營(依法須經批准的項目,經相關部門批准後方可開展經營活動,具體經營項目以審批結果為準)。一般項目:第二類醫療器械銷售,第一類醫療器械銷售(除依法需批准的項目外,憑營業執照開展經營活動)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.